Navigation Links
TorreyPines Therapeutics to Present at ThinkEquity's ThinkClinic Conference
Date:9/27/2007

LA JOLLA, Calif., Sept. 27 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that Dr. Neil Kurtz, President and Chief Executive Officer of TorreyPines, will present at ThinkEquity's ThinkClinic: An Educational Forum for Healthcare Investors Conference in New York City on Thursday, October 4th at 1:45 p.m., Eastern.

A webcast of Dr. Kurtz's presentation will be available live. You can access the webcast at: http://www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel small molecules to treat diseases and disorders of the central nervous system (CNS). Led by an accomplished management team, TorreyPines is leveraging novel drug targets and technologies to potentially deliver new CNS therapies for chronic pain, including migraine and neuropathic pain; and cognitive disorders, including cognitive impairment associated with schizophrenia and Alzheimer's disease. Further information is available at http://www.torreypinestherapeutics.com.


'/>"/>
SOURCE TorreyPines Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
3. Wisconsin firms to present at Cleantech venture capital event
4. New Sonic Foundry search engine finds words, phrases in video presentations
5. Lone Wisconsin firm to present at InvestMidwest
6. Sonic Foundry creates search engine for 7,000 expert video presentations
7. InvestMidWest calls for business presentations
8. Wicab to present BrainPort at Boston conference
9. Three more Wisconsin firms to present at venture forum
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. New Health and Human Services representative for Midwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...tion of esophagus eliminated in 90 percent ...if., May 15 /- BARRX Medical, Inc., t...ous conditions of the,digestive tract, today annou...center U.S. study were free of the highest-risk of...endoscopic treatment using the,HALO360 ablation sy...
(Date:5/15/2008)...Newswire-FirstCall/ -- Indevus,Pharmaceuticals, In...ny will,present at the Rodman & Renshaw 5th Annual...:55 p.m. local time (10:55 a.m. EDT) and at the 20...s Conference on Thursday, May,29, 2008 at 10:00 a....ill,be web cast live and may be accessed by visiti...
(Date:5/15/2008)...re-FirstCall/ -- Escalon Medical Corp.,(Nasdaq: E... quarter and,nine months ended March 31, 2008., F...ue increased 18% to,$8,139,000 compared with $6,90.... Product revenues were driven by increased sales ...enue for the third quarter of fiscal 2008 totaled ...
(Date:5/15/2008)...swire-FirstCall/ -- ImaRx Therapeutics,Inc. (Nasd...g and,commercializing therapies for vascular disor...st quarter ended March 31, 2008 and discussed rece..., -- Entered into agreement with Abbott Laborator... non-recourse promissory note issued in connection...
Breaking Biology Technology:New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus 2New Study Reports That Ablative Therapy With HALO360 Device Effectively Treats Highest-Risk Category of Barrett's Esophagus 3Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences 2Indevus Pharmaceuticals Scheduled to Present at Upcoming Investor Conferences 3Escalon(R) Reports Third Quarter Fiscal 2008 Results 2Escalon(R) Reports Third Quarter Fiscal 2008 Results 3Escalon(R) Reports Third Quarter Fiscal 2008 Results 4Escalon(R) Reports Third Quarter Fiscal 2008 Results 5Escalon(R) Reports Third Quarter Fiscal 2008 Results 6Escalon(R) Reports Third Quarter Fiscal 2008 Results 7Escalon(R) Reports Third Quarter Fiscal 2008 Results 8ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 2ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 3ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 4ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 5ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 6ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results 7
...rookfield, Wis. Check-processing firm Fiserv i...s Commonwealth Bank of Australia, National Austra...e the Vipro check processing system. If negotiatio...ld form a joint venture that would have all proces...in Conjugons board of directors , Madison, Wis. ...
...n communications firm Rathmann-Fronbery LLC . He ...wo clients. , ,Wisconsin manufacturers are relyin...East, creating a demand for Asian management talen...onals can be time-consuming and costly, but techno...y some recruiters to shrink the distances involved...
...ased sales of its media products and tripled its 2...last year, the company said on Thursday. , ,That l...f $5.4 million. Last year, operational losses were...d business units led to a profit of $1.5 million. ...ive , a presentation system that can combine digit...
...is at an all-time low their confidence in search e...mers what advertising does not: relevance. , ,Toda...A 2004 study of search engine user attitudes ( Cli...at nearly 80 percent of Internet users use search ... rely on search engines daily. The IProspect study...
Other Biology Technology:Lack of broadband hamstrings international videoconferencing 2Lack of broadband hamstrings international videoconferencing 3Your customer is a search engine 2
(Date:5/15/2008)... researchers has developed a simple artificial cel...unction of two of the most basic cell components: ...s fluid that surrounds the structures in living ce...rugs that take advantage of properties of cell org... The team,s findings will be published later this ...
(Date:5/15/2008)...ivided into two separate groups within Africa for ...University mathematician. Climate change, reductio...sed and maintained the separation. , Dr. Saharo... at Tel Aviv University, worked with team leader D...ze African DNA. Their goal was to study obscure po...
(Date:5/15/2008)...8) Argonne National Laboratory has signed a memor...ational Laboratory (SRNL) to collaborate on nuclea...jects in support of critical U.S. Energy Departmen...ies. , "The MOU allows Argonne to remain a leade...bert Rosner said. "Argonne has the nation,s larges...
(Date:5/15/2008)...ers Karen Staehling-Hampton, Ph.D., Managing Direc...D., Investigator, collaborated with colleagues fro...se spinal mutations in chick and mouse model syste...ith congenital vertebral abnormalities. , The d...e American Journal of Human Genetics. , Working...
Breaking Biology News(10 mins):Simple model cell is key to understanding cell complexity 2Long lost sisters 2Argonne-SRNL agreement supports critical DOE, national priorities 2Stowers Institute researchers identify gene linked to vertebral defects in patient populations 2Barr Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8 2007 3008 1Barr Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8 2007 3008 2Barr Will Host Calendar 2007 Third Quarter Earnings Conference Call on November 8 2007 3008 3Riverside Partners Teams with Management to Acquire GEMCITY Engineering 26 Manufacturing 3006 1Riverside Partners Teams with Management to Acquire GEMCITY Engineering 26 Manufacturing 3006 2Healthways Enters German Healthcare Market 3004 1Healthways Enters German Healthcare Market 3004 2New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti Cancer Potential Of Peregrines Anti PS Technology Platform 1096 1New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti Cancer Potential Of Peregrines Anti PS Technology Platform 1096 2New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti Cancer Potential Of Peregrines Anti PS Technology Platform 1096 3New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti Cancer Potential Of Peregrines Anti PS Technology Platform 1096 4
...e scientists replace pricey solvents with cheap pr...large-scale manufacture of fluorescent quantum dot...new method of replacing the pricey solvents used i... commonplace at industrial chemical plants. , Rice...f the Center for Biological and Environmental Nano...
...territorial species with polygynous mating systems...on. At the gross level, such phenotypic variation ...y, as well as of weapon function and performance. ...he American Naturalist, A. Kristopher Lappin (Nort...oma State University) use the eastern collared liz...
...earchers at Purdue University have taken a step to...cal imaging technique that works by shining a lase...jected into the bloodstream. , In tests with mice,...ter than conventional fluorescent dyes, including ...gical imaging to study the inner workings of cells...
...lt stem cells taken from bone marrow are the "shoo...ts have been speculating that the cells might be a... and replace defective tissue. Such cells are seen...muscle diseases. However, a study currently being ... some sobering findings: although the cells are ab...
Other Biology News:The right drug at the right time 2The right drug at the right time 3Purdue's gold nanorods brighten future for medical imaging 2Research casts doubt on circulating stem cells 2Research casts doubt on circulating stem cells 3
Recombinant Rat Leptin, CF
VACUGENE PUMP 110V, 1 EA. Category: Nucleid Acid Detection Systems.
delta-like 1 homolog (Drosophila)
Cryopreservation Service from AbD Serotec
Biology Products: